2019 2018 2017 2016 2015 2014 2013 2012 2011

Caballero-Velazquez, T, Quijano-Ruiz, B, Lopez-Corral, L, Rodriguez-Otero, P, Cuesta-Casas, MA, Blanquer-Blanquer, M, Herrera-Arroyo, C, Rojas-Alvarez-Ossorio, L, Martinez-Atienza, J, Macias-Sanchez, M, Mata, RC, Perez-Simon, JA. Treatment of steroid refractory acute graft-versus-host disease with allogenic adipose tissue-derived mesenchymal stromal cells. A multicenter phase I/II clinical trial. HUM GENE THER 30 88-88. 01/11/2019. F.I.:3,855 
Penalver, FJ, Marquez, JA, Duran, S, Giraldo, P, Martin, A, Montalban, C, Sancho, JM, Ramirez, MJ, Terol, MJ, Capote, FJ, Gutierrez, A, Sanchez, B, Lopez, A, Salar, A, Rodriguez-Caravaca, G, Canales, M, Caballero, MD, Lopez, JLB, Carbonell, F, Bordas, SF, Lopez, PF, Persona, EP, Guillermo, AL, Martin, RH, Mayans, JR, Palomera, L, Ceballos, EP, Hernandez, JAQ, Grau, RR, de la Cruz, F, Salinas, AS, GELTAMO Spanish Lymphoma Cooperati. Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial. CANCER MED-US 8 6955-6966. 01/11/2019. F.I.:3,357 [doi:10.1002/cam4.2555]
Garcia-Alvarez, M, Garcia, JL, Alonso-Alvarez, S, Magnano, L, Rivas-Delgado, A, Mozas, P, Maldonado, R, Jimenez-Ubieto, A, Bastos, M, De Cabo, E, Pardal, E, Blanco, O, Gutierrez, N, Garcia-Sanz, R, Gonzalez, M, Martin, A, Lopez-Guillermo, A, Caballero, MD, Alcoceba, M. THE GAIN OF THE 4Q28 REGION IS ASSOCIATED WITH HIGHER RISK OF HISTOLOGICAL TRANSFORMATION IN FOLICULAR LYMPHOMA. HAEMATOLOGICA 104 28-28. 21/10/2019. F.I.:7,570 
Parra, ML, Villaron, EM, Veiga, A, Redondo, A, Muntion, S, Campelo, MD, Riesco, S, Perez, E, Cabrero, M, Martin, AA, Corral, LL, Vazquez, L, Caballero, MD, Sanchez-Guijo, F. TREATMENT OF THE HAEMORRHAGIC CYSTITIS WITH ALLOGENEIC MESENCHYMAL CELLS OF BONE MARROW. EXPERIENCE OF THE UNIVERSITY OF SALAMANCA COMPLETE CARE. HAEMATOLOGICA 104 96-96. 21/10/2019. F.I.:7,570 
Achury, CA, Diaz, LG, Montes, C, Garcia, R, Penarrubia, M, Fernandez, S, Vidal, M, Queizan, J, Hermida, G, Caballero, D, Tamayo, P. Prognostic value of total metabolic tumor volume and total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography / computed tomography in Hodgkin lymphoma. Preliminary Results. EUR J NUCL MED MOL I 46 559-559. 01/10/2019. F.I.:7,182 
Gonzalez, LGD, Achury, CA, Montes, C, Martin, A, Penarrubia, M, Fernandez, S, Vidal, M, Queizan, J, Hermida, G, Caballero, D, Tamayo, P. Prognostic Value of Total Metabolic Tumor Volume and Total Lesion Glycolysis of baseline 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Diffuse Large B-Cell Lymphoma. EUR J NUCL MED MOL I 46 563-563. 01/10/2019. F.I.:7,182 
Ortí G, García-Cadenas I, López L, Pérez A, Jimenez MJ, Sánchez-Ortega I, Alonso L, Sisinni L, Fox L, Villacampa G, Badell I, de Heredia CD, Parody R, Ferrà C, Solano C, Caballero D, Martino R, Querol S, Valcárcel D. Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation.. BONE MARROW TRANSPL 54 1133-1137. 01/07/2019. F.I.:4,674 [doi:10.1038/s41409-018-0422-z]
Ortí G, García-Cadenas I, López-Corral L, Pérez A, Jimenez MJ, Sánchez-Ortega I, Alonso L, Sisinni L, Fox L, Villacampa G, Badell I, de Heredia CD, Parody R, Ferrà C, Solano C, Caballero D, Martino R, Querol S, Valcárcel D. Author Correction: Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation.. BONE MARROW TRANSPL 54 1176-1176. 01/07/2019. F.I.:4,674 [doi:10.1038/s41409-019-0471-y]
Prieto-Garcia, L, Alonso-Alvarez, S, Alcoceba, M, Delgado, M, Gutierrez, N, Lopez-Corral, L, Perez-Lopez, E, Baile, M, Cabrero, M, Martin, AA, Navarro-Bailon, A, Diaz, LG, Tamayo, P, Vazquez, L, Martin, A, Caballero, MD. Long term follow-up after stem-cell transplant in transformed DLBCL: A single centre experience. BONE MARROW TRANSPL 54 458-459. 01/07/2019. F.I.:4,674 
Garcia-Alvarez, M, Alonso-Alvarez, S, Prieto-Conde, I, Jimenez, C, Sarasquete, ME, Chillon, MC, Medina, A, Balanzategui, A, Maldonado, R, Anton, A, Puig, N, Rodriguez, M, Blanco, O, Tamayo, P, Gonzalez-Calle, D, Martin, A, Garcia-Sanz, R, Gonzalez, M, Caballero, MD, Alcoceba, M. Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas. BLOOD CANCER J 9 -. 17/06/2019. F.I.:7,895 [doi:10.1038/s41408-019-0213-9]